Outing HIV (or, the tailor retailored).
Mascolini
M
M
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy; D000328:Adult; D000349:Africa / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002648:Child; D002681:China / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005060:Europe / Q000453:epidemiology; D005260:Female; D006678:HIV / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015528:HIV Seroprevalence; D006467:Hemophilia A / Q000150:complications; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D016753:Interleukin-10 / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008297:Male; D017410:Practice Guidelines as Topic; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D007376:Interleukin-2; D012367:RNA, Viral; D016753:Interleukin-10